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Nel-like protein 1 (NELL-1) is an osteoinductive molecule associated with premature calvarial suture
closure. Here we identiﬁed apoptosis related protein 3 (APR3), a membrane protein known as a pro-
liferation suppressor, as a binding protein of NELL-1 by biopanning. NELL-1 and APR3 colocalized on
the nuclear envelope of human osteoblasts. NELL-1 signiﬁcantly inhibited proliferation of osteo-
blasts co-transfected with APR3 through further down-regulation of Cyclin D1. The co-expression
of NELL-1 and APR3 enhanced Ocn and Bsp expression and mineralization. RNAi of APR3 signiﬁ-
cantly reduced the differentiation effect of NELL-1. These ﬁndings suggest that the effects of
NELL-1 on osteoblastic differentiation and proliferation are partly through binding to APR3.
Structured summary of protein interactions:
APR3 physically interacts with NELL1 by pull down (View interaction)
APR3 and NELL1 colocalize by ﬂuorescence microscopy (View interaction)
NELL1 physically interacts with SMEK1 by phage display (View interaction)
NELL1 physically interacts with EIF4B by phage display (View interaction)
NELL1 physically interacts with APR3 by anti bait coimmunoprecipitation (View interaction)
NELL1 physically interacts with EIF5B by phage display (View interaction)
NELL1 physically interacts with DNTTIP2 by phage display (View interaction)
NELL1 physically interacts with EEF1A1 by phage display (View interaction)
NELL1 physically interacts with Nexilin by phage display (View interaction)
NELL1 physically interacts with PLCG1 by phage display (View interaction)
NELL1 physically interacts with APR3 by phage display (View interaction)
NELL1 physically interacts with SLTM by phage display (View interaction)
NELL1 physically interacts with SSRP1 by phage display (View interaction)
NELL1 physically interacts with NOL10 by phage display (View interaction)
 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Nel-like protein 1 (NELL-1) is a novel protein that is overexpres-
sed in the congenital craniofacial deformity craniosynostosis (CS)
resulting in calvarial osteoblast differentiation and premature clo-
sure of cranial sutures [1]. Various animal models have conﬁrmedon behalf of the Federation of Euro
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ne sialo protein; Ocn, osteo-
ted transcription factor 2
ciences 30-113, University of
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ucla.edu (K. Ting).NELL-1’s ability to promote osteoblastic differentiation and
mineralization in vitro and bone regeneration in vivo [2,3]. In vitro
studies have also shown that NELL-1 overexpression promotes
osteoblastic differentiation and mineralization, while down
regulation of NELL-1 inhibits osteoblastic differentiation [3]. Thus,
NELL-1 is believed to be an important factor involved in osteogen-
esis-associated signaling pathways. It was reported that NELL-1
transiently activates the MAPK signaling cascade and induces
runt-related transcription factor 2 (Runx2) phosphorylation and
also promotes the rapid intracellular accumulation of Tyrosine-
phosphorylated proteins [4]. These ﬁndings suggest that NELL-1,
a secreted protein [5], may bind to a speciﬁc membrane receptor(s)
which then mediates the activation of intracellular signaling path-
ways. To identify the potential membrane associated receptor(s) orpean Biochemical Societies.
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phage display system using NELL-1 as bait and found apoptosis re-
lated protein 3 (APR3) as the primary candidate.
APR3 was ﬁrst cloned from HL-60 cells treated with all-trans-
retinoic acid (ATRA) and was found to induce cell differentiation
and apoptosis [6]. Although there have been very few studies on
the function of APR3, it was reported that APR3 overexpression
causes G1/S phase arrest, which may result from APR3’s dramatic
reduction of Cyclin D1 expression [7]. APR3 overexpression was re-
ported to signiﬁcantly reduce Cyclin D1 promoter activity and de-
crease endogenous Cyclin D1 expression both at mRNA and protein
levels. Structurally, APR3 is potentially a transmembrane protein. It
is predicted to contain a signal sequence at the N-terminus, fol-
lowed by an EGF-like domain, a transmembrane region and an
intracellular region at the C-terminus [7–9]. APR3 was demon-
strated on the cell surface of MCF-7 (human breast cancer cells)
transfected in vitro with APR3 expression plasmid using immuno-
ﬂuorescence staining [7]. In our current study, we show a novel
cellular distribution of APR3 on the nuclear envelope/membrane
in human osteosarcoma cell lines Saos2 and U2OS, as well as in
non-tumor cell lines COS-7 and 293T by confocal microscopy.
The physical interaction of NELL-1 and APR3 demonstrated by
co-immunoprecipitation and co-localization on the nuclear enve-
lope in Saos2 and U2OS cells deﬁnitively conﬁrm APR3 as a direct
binding protein of NELL-1. Results of functional analysis on cell
proliferation and osteoblast differentiation indicate APR3 binding
as a potential mechanism by which NELL-1 promotes osteoblastic
differentiation while suppressing cell proliferation.
2. Materials and methods
2.1. Cell culture
Saos2, U2OS, Cos-7, 293T, HL-60, Raji and M-10B4 cells were
cultured as described in Supplementary materials and methods.
2.2. T7 Saos2 cDNA library construction
Total RNA was isolated from Saos2 cells using Trizol reagent
(Invitrogen) and mRNA was obtained using Oligotex Direct
mRNA Mini Kit (Qiagen). cDNA was synthesized following man-
ufacturer’s protocol from T7Select10-3 OrientExpress™ cDNA
Cloning System (Novagen) using a random primer. The cDNA in-
serts were ligated into T7Select 10-3b vector arms and packaged
into T7 phages (Novagen). BLT5403 Escherichia coli strain was
used as the phage library host. The resulting phage library con-
tained 2.1  106 independent clones/ml and was ampliﬁed once
to reach a titer of 1.6  1010 pfu/ml.
2.3. Phage library biopanning
An aliquot of the ampliﬁed phages was allowed to bind to NELL-
1 puriﬁed protein and screened for several rounds of biopanning as
described in Supplementary materials and methods.
2.4. Plaque PCR ampliﬁcation and analysis
The phage DNA was then ampliﬁed by PCR and analyzed, as de-
scribed in Supplementary materials and methods.
2.5. Plasmid construction
NELL-1 and APR3 expression plasmids were constructed and
conﬁrmed as described in Supplementary materials and methods.2.6. Co-immunoprecipitation and western blotting
Overexpressed NELL-1 and/or APR3 were co-immunoprecipi-
tated with biotinylated anti-NELL-1 monoclonal antibody and/or
mouse anti-FLAG monoclonal antibody M2 (Sigma), and then ana-
lyzed by western blot, as described in Supplementary materials
and methods.
2.7. Co-localization of NELL-1 and APR3
293T, Saos2 and U2OS cells were transfected with ﬂuorescence
tagged NELL-1 and/or APR3 plasmids and visualized by confocal
microscope as described in Supplementary materials and methods.
2.8. MTS assay, alkaline phosphatase activity assay and Alizarin red
staining
Saos2 and U2OS cells were transfected with Nell1-His and/or
Apr3-FLAG or corresponding empty vectors. MTS assay for prolifer-
ation and ALP assay for differentiation as well as Alizarin red stain-
ing for mineralization were performed as described in
Supplementary materials and methods.
2.9. Real-time PCR
Saos2 and U2OS cells were transfected as described and total
RNA were isolated. Reverse transcription PCR and real-time PCR
were performed, as described in Supplementary materials and
methods.
3. Results
3.1. Identiﬁcation and conﬁrmation of APR3 as a direct binding protein
of NELL-1
To determine how NELL-1 regulates osteoblastic differentiation
and mineralization, we set a phage display system to identify the
protein with which NELL-1 interacts (Fig. 1A). We constructed a
T7 library that expressed different proteins and polypeptides from
cDNA fragments of Saos2 cells, a human osteosarcoma cell line of-
ten used as osteoblastic cells. The quality of the library was exam-
ined by plaque assay. The titer was 2.1  106 pfu/ml originally and
1.6  1010 pfu/ml after one time ampliﬁcation. With puriﬁed re-
combinant human NELL-1 protein (rhNELL-1) mobilized on an ELI-
SA plate as bait. The library was screened, and candidates were
chosen and analyzed. More than 100 candidates among all the sin-
gle plaques after four rounds of biopanning were analyzed. Cellular
distributions and functional properties of representative plaques
are summarized in Supplemental data (Supplementary Table 1).
Based on the hypothesis that NELL-1 initiates its signaling cascade
through binding to a speciﬁc receptor or receptors on the cell sur-
face, the identiﬁcation of a transmembrane protein was our pri-
mary focus. Cross-referencing the candidates with information
from structural molecule annotation, previous literature, and bio-
informatics analysis enabled us to identify APR3, a potential trans-
membrane protein [7], as the candidate that warranted further
characterization. The candidate clone of APR3 from our phage li-
brary covers amino acid 54 up to the stop codon (Fig. 1B), identical
to APR3 isoform B. To further verify the physical interaction be-
tween NELL-1 and APR3, co-immunoprecipitation of NELL-1 by
anti-APR3-FLAG or APR3 by anti-NELL-1 was performed and con-
ﬁrmed by co-overexpression of both proteins in Cos-7 cells
(Fig. 2A). Similar results were obtained from 293T cells (data not
shown). However, multiple attempts were unsuccessful in
Fig. 1. Identiﬁcation of APR3 as a NELL-1 binding protein by phage display. (A) cDNA library was constructed from human osteosarcoma cell line Saos2 and packaged with T7
phage. The library was probed by puriﬁed human NELL-1 protein. After 4 rounds of biopanning, most of the non-speciﬁc binding phages were washed off; the remaining
phages were considered binding candidates. (B) cDNA inserts from candidate plaques were ampliﬁed by PCR using speciﬁc primers from T7 phage vector. PCR products over
0.5 kb were sequenced and analyzed using bioinformatics method. Among the candidates, APR3 was selected as the primary membrane protein (NCBI blast tools and human
genomic plus transcript database). A candidate sequence was aligned precisely with full-length APR3 isoform b highlighted in dark blue.
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bodies currently available for use in human osteoblastic cells (data
not shown). Unexpectedly, we detected the distinct cellular local-
ization of the APR3-dsRed on the nuclear envelope/membrane of
human osteoblastic cells with confocal microscope (Fig. 2B and
C), which is distinctly different from its cell surface localization de-
scribed in MCF-7 [7]. The nuclear membrane distribution of APR3
was also observed in Cos-7 and 293T cells (data not shown).
Nell-1-EGFP was mainly distributed in the cytoplasm of transfec-
ted osteoblastic cells as previously reported [5]. However, the per-
inuclear condensation of Nell-1-EGFP became signiﬁcantly
prominent when APR3 was co-overexpressed in the same cells
(Fig. 2B). The co-localization of NELL-1 and APR3 was clearly dis-
played predominantly around the nuclear envelope in positive
co-transfected cells, which is indicative of formation of an intracel-
lular binding complex by these two proteins (Fig. 2B and C). Fur-
thermore, we studied the endogenous interaction of these twoproteins in several relevant cell lines in which strong NELL-1 or
APR3 RNA expression has been reported using a co-immunoprecip-
itation assay or IHC for co-localization. Unfortunately, no deﬁnitive
data resulted from these experiments primarily because of lack of
good cell lines expressing detectable levels of both NELL-1 and
APR3 simultaneously, as well as a lack of good quality antibodies
for APR3 available for this study. (Supplementary Fig. 2).
3.2. APR3 inhibits osteoblast proliferation enhanced by binding to
NELL-1
APR3 was reported to have inhibitory effects on proliferation of
HeLa cells [7]. It is of interest to us to determine whether NELL-1
binding to APR3 affects human osteoblastic cell proliferation.
While no signiﬁcant inhibitory effect was observed with NELL-1
single transfection, we found that transfection of APR3 alone can
signiﬁcantly suppress Saos2 cell proliferation (Fig. 3A) and APR3
Fig. 2. Direct binding and intracellular co-localization of NELL-1 and APR3. (A) APR3 and NELL-1 expression plasmids or empty vectors were cotransfected into Cos-7 cells.
APR3 protein with FLAG tag and NELL-1 protein were pulled down respectively by anti-FLAG afﬁnity gel and Dynabeads Protein G binding with anti-NELL1 antibody. Western
blot was performed after pull down assay. NELL-1 was detected in the APR3 pull down sample, but not in the vector sample. APR3 was detected in the NELL-1 pull down
sample, but not in the vector sample. (B and C) APR3 expression plasmid with red ﬂuorescence tag and NELL-1 expression plasmid with green ﬂuorescence tag were
cotransfected into Saos2 (B) and U2OS (C) cells. Samples were observed by confocal microscope after 48 h of expression. NELL-1 was localized in the cytoplasm of single
positive cells (arrowheads) while APR3 and NELL-1 were found to be co-localized in the perinuclear region and on the nuclear envelope of double positive cells as indicated by
arrows.
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experiments were done using U2OS cells and similar results were
obtained (Fig. 3E and F). In addition, the proliferation of Saos2
and U2OS cells were inhibited by co-transfection of NELL-1 and
APR3 far more signiﬁcantly than by APR3 transfection alone
(Fig. 3A and E). The alteration of Cyclin D1 mRNA and protein
expression was also investigated in Saos2 cells transfected with
APR3, NELL-1 or APR3 + NELL-1 using real time PCR and western
blot. It was previously demonstrated that the cell cycle arrest med-
iated by APR3 involves suppression of Cyclin D1 which plays a ma-
jor role in the control of cell cycle progression [7,10–12]. We
detected that the expression levels of Cyclin D1 mRNA and protein
were signiﬁcantly lower in Saos2 cells transfected with either
NELL-1 or APR3 in comparison to cells transfected with correspond-
ing empty vectors. Furthermore, this down-regulation of Cyclin D1
was signiﬁcantly enhanced in Saos2 cells co-transfected with NELL-
1 and APR3 and much greater than in either single transfection
(Fig. 3C and D). When endogenous APR3 was silenced in U2OS,
the mRNA level of Cyclin D1 was found to be increased, and that
it increased even more with NELL-1 overexpression and APR3 siR-
NA co-treatment (Fig. 3G). These data suggest the possibility that
NELL-1 and APR3 exert a synergistic inhibitory effect on human
osteosarcoma cell proliferation through signiﬁcant down-regula-
tion of the critical cell cycle molecule Cyclin D1. Collectively,
APR3 and NELL-1, through binding to each other, signiﬁcantly sup-
press human osteosarcoma Saos2 and U2OS cell proliferation, andinstead drive these cells toward osteoblastic differentiation and
terminal mineralization.
3.3. NELL-1 promotes osteoblastic differentiation and mineralization
partially through binding to APR3
In our previous study, we reported that NELL-1 is capable of
inducing osteoblastic differentiation and mineralization of preos-
teoblasts in vitro [3]. In this study, we were interested in determin-
ing whether APR3 is required or signiﬁcantly critical for NELL-1 to
mediate its osteogenic effects on human Saos2 and U2OS cells.
Alkaline phosphatase (ALP) assay revealed that NELL-1 and APR3
co-transfection increased ALP activity to the highest level in Saos2
cells at both day 6 and day 9 compared to either NELL-1 or APR3
single transfection (Fig. 4A). At day 9, the most intense mineraliza-
tion was induced in Saos2 cells co-transfected with NELL-1 and
APR3 although the moderate mineralization was also observed in
Saos2 cells transfected with either NELL-1 or APR3 alone (Fig. 4B
and C). On a molecular level, we detected mRNA of bone marker
genes Alp, osteocalcin (Ocn) and bone sialoprotein (Bsp) in Saos2
cells at day 3 post-transfection. Speciﬁcally, the expression of
Ocn and Bsp was increased signiﬁcantly in Saos2 cells co-transfec-
ted with NELL-1 and APR3, and also much higher than that with
NELL-1 single transfection (Fig. 4E and F). To further examine
APR3’s role in NELL-1 mediated osteoblastic differentiation, we
knocked down the endogenous expression of APR3 by siRNA oligos
Fig. 3. APR3 inhibition of osteoblastic proliferation was enhanced by co-overexpression of NELL-1. (A) APR3 and NELL-1 expression plasmids or empty vectors were
cotransfected into Saos2 cells. MTS assay was performed at indicated time points. (B) APR3 siRNA increased Saos2 cell proliferation. (C) Effects on mRNA level of Cyclin D1 in
Saos2 cells were examined by real-time PCR. APR3 and NELL-1 interaction downregulated Cyclin D1 signiﬁcantly. (D) Effects on Cyclin D1 protein level were tested by
western blot 48 h after APR3 and NELL-1 transfection in Saos2 cells. Cyclin D1 was dramatically downregulated after APR3 and NELL-1 co-transfection. (E) Parallel experiment
in U2OS cells. Cell proliferation was decreased when APR3 and NELL-1were overexpressed. (F) Endogenous APR3 knockdown increased U2OS cell proliferation. (G) The mRNA
level of Cyclin D1 in U2OS cells increased under APR3 silencing condition. Samples were prepared in triplicate (⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.005).
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Fig. 4. NELL-1 induced osteoblast differentiation and mineralization were signiﬁcantly enhanced by APR3 co-overexpression. (A) APR3 and NELL-1 expression plasmids or
empty vectors were co-transfected into Saos2 cells. ALP activities were examined at day 6 and day 9. (B and C) Mineralization was examined by Alizarin red staining at day 6
and day 9 after co-transfection indicating that NELL-1 and APR3 have greater effects when co-overexpressed in Saos2 cells in promoting osteoblast terminal differentiation.
Representative Alizarin red staining images indicate mineralization level at day 9. (D–F) Bone marker genes Bsp and Ocn were signiﬁcantly upregulated in NELL-1 and APR3
co-transfected Saos2 cells while mRNA expression of Alp remained unchanged at day 3 post-transfection. Samples were prepared in triplicate (⁄P < 0.05, ⁄⁄P < 0.01,
⁄⁄⁄P < 0.005).
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in Saos2 cells transfected with NELL-1. As shown in Fig. 5A, the best
knockdown efﬁcacy of over 80% was achieved with APR3 siRNA-3
oligo. In contrast to overexpression, the knockdown of APR3 in
Saos2 cells resulted in lower level expression of Alp, Ocn and Bsp
with or without NELL-1 transfection (Fig. 5B–D). Furthermore,
NELL-1 induced mineralization was partially blocked by knocking
down endogenous APR3 (Fig. 5E and F). These data indicate that
APR3 is an important co-factor of NELL-1 in promoting osteoblastic
differentiation and terminal mineralization of human osteosar-
coma Saos2 cells.
4. Discussion
NELL-1 is a novel osteogenic factor identiﬁed from its upregula-
tion in cranial bones of patients with CS [1]. Previous studies have
demonstrated that NELL-1 is a secreted protein [5] which likely
interacts with certain cell surface membrane receptor(s) thereby
mediating its downstream signaling pathways. The original pur-
pose of our work was to identify the membrane receptor(s) that
physically interacts with NELL-1 and mediates NELL-1’s function
on human osteosarcoma cell lines Saos2 and U2OS proliferation
and osteoblastic differentiation. We constructed a phage library
encoding various protein fragments from the Saos2 cell line and
screened binding proteins using recombinant human NELL-1 pro-
tein as bait by multiple rounds of biopanning. Among the over
100 identiﬁed candidates, APR3, previously reported as a trans-membrane protein and located on the cell surface of MCF-7 cells
[7], was a promising candidate as a ‘‘receptor-like’’ NELL-1 binding
protein. Unexpectedly, our results indicated that APR3 was located
dispersedly in the cytoplasm, but predominantly concentrated
around/on the nuclear envelope in Saos2 and U2OS cells as well
as in other non-osteoblastic cell lines including 293T and Cos-7.
To make certain that the relatively large size of ﬂuorescent tag in
our APR3 construct would not affect its subcellular localization,
we also used APR3 with small FLAG tag for transfection and ob-
served a similar localization pattern in those same cell lines (Sup-
plementary Fig. 1A). Interestingly, the cytoplasmic localization of
APR3 was also the major distribution pattern in MFC-7 cells trans-
fected with our APR3 constructs although the cell membrane local-
ization was seen in some transfected cells (Supplementary Fig. 1B).
This ﬁnding suggests that APR3 cellular localization may vary in
different cell types, allowing it to regulate different signaling path-
ways for cell-type speciﬁc functions. Nevertheless, the ﬁnding of a
nuclear envelope/membrane localization of APR3 directed our cur-
rent study towards exploring an intracellular protein, rather than a
cell surface protein, that interacts with NELL-1 by using plasmid
co-transfection strategy. The subsequent effects of this interaction
on proliferation and osteoblastic differentiation of Saos2 and U2OS
cells were also analyzed. It is noteworthy that human NELL-1 has
been identiﬁed not only as an extracellular signaling molecule
[4,13,14], but also as an intracellular protein capable of directly
interacting with a speciﬁc subtype of protein kinase C (PKC) [5].
It would not be surprising if the existence of a cytoplasmic form
Fig. 5. Endogenous APR3 knock-down decreases NELL-1 upregulation of osteoblastic mineralization. (A) APR3 knock down efﬁciency test in Saos2 cells showed that siRNA3
among three APR3 siRNA oligos provided by Invitrogen was most effective with over 80% endogenous APR3 mRNA knock down 48 h post-transfection using current
experimental conditions. (B–D) Bone marker gene levels were examined 9 days after endogenous APR3 knock down in Saos2 cells. Consistent with mineralization results,
mRNA levels of Bsp and Ocn were signiﬁcantly decreased after APR3 knock down. (E and F) Mineralization of Saos2 was signiﬁcantly reduced when endogenous APR3 was
knocked down by siRNA3 with and without NELL-1 overexpression at day 9. Non-speciﬁc negative control siRNA and pcDNA 3.1-his-myc empty vector were transfected as
control. Samples were prepared in triplicate (⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.005).
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experimentally since an alternative promoter utility has been iden-
tiﬁed on transcription of human NELL-1 (DBTSS: http://
dbtss.hgc.jp/). Therefore, the intracellular interaction of NELL-1
with APR3 is unexpected, but not entirely unlikely, and its func-
tional signiﬁcance worthy of further exploration. The physical
interaction between NELL-1 and APR3 was further conﬁrmed by
co-immunoprecipitation with Cos-7 cells co-transfected with
NELL-1 and APR3-FLAG expression plasmids. However, the critical
experiment to demonstrate the interaction between endogenous
NELL-1 and APR3 in human Saos2 or U2OS cells was severely ham-
pered due to the lack of speciﬁcity of all three anti-APR3 antibodies
currently available in the ﬁeld. Furthermore, the multiple cell lines
with detectable RNA levels of either NELL-1 (Raji cells [5]) or APR3
(HL-60 and 293T [7]) were used to maximize the chance of endog-
enous binding of these two proteins. Unfortunately, these experi-
ments did not result in any deﬁnitive data either (Supplementary
Fig. 2). Using confocal microscope imaging on Saos2 cells co-trans-
fected with red and green ﬂuorescent-tagged APR3 and NELL-1, the
distinct alteration in the subcellular distribution of NELL-1 in
NELL-1/APR3 double positive cells in comparison to NELL-1 single
positive cells strongly indicated the formation of an intracellular
NELL-1/APR3 complex on the nuclear envelope. We speculate that
this direct intracellular interaction between NELL-1 and APR3 may
play a signiﬁcant role in regulating human osteoblastic cell differ-
entiation as both molecules have been identiﬁed previously as crit-
ical components in the regulation of cell proliferation and
differentiation [2–4,7,13,16]. Notably, a subset of preliminary data
presented in Supplementary Fig. 3, the TSPN and EGF-like domains
of NELL-1 did not appear to play crucial roles in binding of NELL-1
to APR3 as the binding capacity was not changed signiﬁcantly
when the fragment-deleted NELL-1 constructs were transfected.
However, the binding of NELL-1 without TSPN domain showed a
relative weak afﬁnity, suggesting that TSPN domain may be more
important than the other examined domains for further investiga-
tion. More deﬁned deletion of NELL-1 domains of TSPN and EGF
will be carefully constructed and investigated in future studies
for identifying interactive components of NELL-1 and APR3.
In ATRA treated cells, APR3 was signiﬁcantly upregulated
resulting in G1/S phase cell arrest leading to cell differentiation
[7]. It also has been reported that NELL-1 can promote osteoblastic
differentiation without promoting cellular proliferation in adeno-
viral NELL-1 transduced MC3T3 and BMSCs [3]. However, the
underlying mechanisms and signal transduction pathways remain
unclear. In this study, we focused on the changes on Cyclin D1 at
the mRNA and protein levels after NELL-1 and APR3 were intro-
duced into Saos2 and U2OS human osteosarcoma cells since Cyclin
D1 has been identiﬁed as a critical factor in APR3 mediated sup-
pression of cell cycle in G1/S phase. Interestingly, the signiﬁcant
inhibition of cell proliferation occurred only when APR3 and
NELL-1 were co-transfected into target cells. Both APR3 and NELL-
1 single transfection could also reduce the expression of Cyclin
D1 to a certain extent however, this modest reduction, in contrast
to the greater reduction achieved by co-transfection with both
APR3 and NELL-1, was incapable of affecting cell proliferation sig-
niﬁcantly although slight suppression of cell growth was observed
in both single transfection at certain time points. MTS assay was
done after knock down of endogenous APR3 by siRNA, which fur-
ther veriﬁed APR3’s inhibitory function on osteoblastic prolifera-
tion (Fig. 3B and G). These results clearly demonstrate that
binding to APR3 is required for NELL-1’s inhibitory role on the pro-
liferation of Saos2 and U2OS human osteosarcoma cells partially
through further down-regulation of Cyclin D1 expression.
In addition to their critical roles on cell proliferation, the signif-
icance of APR3 binding on NELL-1’s osteogenic effects was further
evaluated by in vitro osteoblastic differentiation of Saos2 cells andconﬁrmed with APR3 siRNA knock down strategy. NELL-1 was pre-
viously identiﬁed as one of the downstream mediators of Runx2,
which is essential for osteogenesis [16,17]. We found that the
mRNA levels of important bone marker genes such as Bsp and
Ocn were signiﬁcantly upregulated by APR3 and NELL-1 respec-
tively, while ALP activity was increased by single transfection of
APR3 or NELL-1, and co-transfection of both. Notably, a synergistic
increase in both Bsp and Ocn mRNAwas observed only when NELL-
1 and APR3 were co-overexpressed in Saos2 cells. Moreover, the
mineralization of Saos2 cells was induced by either NELL-1 or
APR3 alone at moderate levels, but co-transfection induced the
highest level of mineralization among all treatment groups. On
the other hand, the application of APR3 siRNA signiﬁcantly inhib-
ited the upregulation of bone marker mRNA expression and miner-
alization induced by either APR3 alone or co-transfection of APR3
and NELL-1 in Soas2 cells. Collectively, these data indicate for the
ﬁrst time that APR3, a molecule directly regulated by two critical
transcriptional factors NFAT and NFjB [18], is capable of inducing
critical bone marker genes and terminal osteoblastic differentia-
tion of Saos2 cells in osteoblastic differentiation medium. More
importantly, the synergistic effects on promoting osteoblastic dif-
ferentiation of Saos2 cells by co-transfection of APR3 with NELL-1
further demonstrated the functional signiﬁcance of NELL-1 binding
to APR3 with respect to NELL-1’s osteogenic property.
One of the proposed mechanisms underlying NELL-1’s osteo-
genic effects involves increasing the phosphorylation of Runx2,
which in turn actively regulates osteogenesis [4]. It has been re-
ported that the level of Runx2 can be downregulated by Cyclin
D1 through promotion of its degradation [19]. It remains to be seen
whether the signiﬁcant decrease in Cyclin D1 level caused by APR3
binding to NELL-1 results in further stabilization of Runx2 and
enhancement of its bioactivity, ultimately resulting in its synergis-
tic effects in promoting Saos2 cell differentiation.
Prospectively, it is also of interest to further investigate whether
the nuclear membrane localization of the NELL-1 and APR3 com-
plex could function as the signaling bridge to the nucleus for cyto-
plasmic retinoic acid (RA), which is the core molecule that acts
through binding nuclear receptors, in ATRA signaling pathway
[20]. In addition to its pro-osteoblastic property, the critical roles
of the direct interaction between APR3 and NELL-1 in inducing tu-
mor cell differentiation and/or apoptosis through ATRA and/or
other pathways would not be surprising as both NELL-1 and
APR3 are suggested to have such capacities in previous reports
[7,13,21].
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